跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 146 条关于
“IBI3042”
全部
146
临床试验
128
药物
6
机构
0
资讯
12
4个月前
Innovent Unveils Next-Generation Obesity Pipeline at ADA 2026, Featuring Oral Daily and Weekly GLP-1 Candidates, Amylin Analog, and INHBE siRNA
去年
Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer Trial
2年前
Innovent and SanegeneBio Initiate Phase 1 Trial of IBI3016 for Hypertension
10个月前
Innovent and SanegeneBio Report Promising Phase 1 Results for IBI3016 siRNA Hypertension Therapy
9个月前
Innovent's Trispecific Antibody IBI3003 Shows 83.3% Response Rate in Heavily Pretreated Multiple Myeloma Patients
去年
Innovent Highlights IBI343 Data in Pancreatic Cancer at ESMO Asia 2024
去年
Innovent's IBI343 Receives Breakthrough Therapy Designation in China for Advanced Pancreatic Cancer
去年
IBI354 Demonstrates Promising Efficacy and Tolerability in HER2-Positive and HER2-Low Breast Cancer
去年
IBI343 Shows Promising Efficacy in CLDN18.2-Positive Gastric Cancer with Improved Safety Profile
9个月前
Innovent Initiates First-in-Human Trial of IBI3011, Novel Anti-IL-1RAP Monoclonal Antibody for Gout Treatment
第 1 页,共 2 页
上一页
下一页